J. Wittliff

发表

Expression of Urokinase‐Type Plasminogen Activator (uPA), its Receptor (uPAR), and Inhibitor (PAI‐1) in Human Breast Carcinomas and Their Clinical Relevance

S. A. Andres, Angelena Edwards, J. Wittliff, 2012, Journal of clinical laboratory analysis.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Anthony Rhodes, Paul Valenstein, Keith Miller, 2010, Archives of pathology & laboratory medicine.

Correction: A Systems Biology Approach Identifies a Regulatory Network in Parotid Acinar Cell Terminal Differentiation

J. Lakshmanan, S. A. Andres, J. Wittliff, 2015, PloS one.

A Systems Biology Approach Identifies a Regulatory Network in Parotid Acinar Cell Terminal Differentiation

J. Lakshmanan, S. A. Andres, J. Wittliff, 2015, PloS one.

Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor–coactivator interactions

Yong Wang, John O Trent, S. Briggs, 2003, Proceedings of the National Academy of Sciences of the United States of America.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).

Anthony Rhodes, Paul Valenstein, Keith Miller, 2010, Archives of pathology & laboratory medicine.

Gender-associated expression of tumor markers and a small gene set in breast carcinoma.

S. A. Andres, J. Wittliff, Irina A. Smolenkova, 2014, Breast.

Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.

N. Wolmark, B. Fisher, E. Fisher, 2001, Journal of the National Cancer Institute.

Angiogenesis-associated sequence variants relative to breast cancer recurrence and survival

Nicole A. Lavender, J. Wittliff, G. Brock, 2010, Cancer Causes & Control.

Influence of estrogen receptor variants in mammary carcinomas on the prognostic reliability of the receptor assay

J. Wittliff, M. Sluyser, 1992, Molecular and Cellular Endocrinology.

Estrogens I: Estrogens and Their Conjugates

S. A. Andres, J. Wittliff, 2005 .

Specific receptors of the steroid hormones in breast cancer.

J. Wittliff, 1974, Seminars in oncology.

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Anthony Rhodes, Paul Valenstein, Keith Miller, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Establishment of uniformity in steroid receptor analyses used in cooperative clinical trials of breast cancer treatment.

J. Wittliff, J. Durant, B. Fisher, 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Estrogens IV: Estrogen-Like Pharmaceuticals

S. A. Andres, J. Wittliff, 2014 .

Regional heterogeneity in breast carcinoma: Thymidine labelling index, steroid hormone receptors, dna ploidy

J. Meyer, J. Wittliff, J. Meyer, 1991, International journal of cancer.

Bromodeoxyuridine labeling for S‐phase measurement in breast carcinoma

J. Wittliff, J. Manes, Enrique Higa, 1993, Cancer.

Estrogen receptors and hormone dependency in human breast cancer.

J. Wittliff, R. Cooper, E. Savlov, 1976, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression.

A. Schally, J. Wittliff, G. Halmos, 1995, Cancer research.

Inhibition of growth of the human malignant glioma cell line (U87MG) by the steroid hormone antagonist RU486.

A. Schally, J. Wittliff, G. Halmos, 1993, The Journal of clinical endocrinology and metabolism.

Estrogens V: Xenoestrogens

S. A. Andres, J. Wittliff, 2005 .

The extracellular thiaminase I of Bacillus thiaminolyticus. I. Purification and physicochemical properties.

J. Wittliff, R. Airth, 1968, Biochemistry.

Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers.

J. Wittliff, R. Purdy, C. V. van Aswegen, 1989, Journal of steroid biochemistry.

Evaluating PERMs as Protein Mimics

J. Wittliff, A. Leduc, A. Spatola, 2001 .

Presence and characteristics of receptors for [D-Trp6]luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer.

E. Jenison, A. Schally, G. Srkalović, 1998, International journal of oncology.

Biosensors for detecting estrogen-like molecules and protein biomarkers.

S. A. Andres, J. Wittliff, Irina A. Smolenkova, 2008, Advances in experimental medicine and biology.

Measurements of DNA and RNA in mammary gland homogenates by the ethidium bromide technique.

J. Wittliff, P. C. Beers, 1975, Analytical biochemistry.

Serine synthesis influences tamoxifen response in ER+ human breast carcinoma.

C. Klinge, J. Wittliff, S. Dougherty, 2020, Endocrine-related cancer.

Reliability of steroid hormone receptor assays: an international study.

V. Jordan, J. Wittliff, Z. Krozowski, 1983, European journal of cancer & clinical oncology.

Pathogenesis and Treatment of Infant Skin Strawberry Hemangiomas: Clinical and in Vitro Studies of Hormonal Effects

J. Wittliff, C. Pang, Gordon Hiroshi Sasaki, 1984, Plastic and reconstructive surgery.

Structural Features and Clinical Significance of Estrogen Receptors

J. Wittliff, S. Hyder, T. Day, 1988 .

Influence of column length and pore size on high-performance ion-exchange chromatography of estrogen and progestin receptors.

J. Wittliff, S. Jung, 1988, Journal of chromatography.

Progestin receptors from tissues either exhibiting or lacking estrogen response mechanisms. Comparison of conventional and high-performance liquid chromatography methodology.

J. Wittliff, S. Hyder, F. Kohrs, 1987, Journal of chromatography.

Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia.

J. Wittliff, T. Day, J. Allegra, 1984, American journal of obstetrics and gynecology.

Steroid receptors and hormone-dependent neoplasia

O. Dapunt, J. Wittliff, 1980 .

Correlations between certain biochemical properties of breast cancer and response to therapy: A preliminary report

J. Wittliff, R. Hilf, E. Savlov, 1974 .

Molecular heterogeneity of cytosolic forms of estrogen receptors from human breast tumors.

J. Wittliff, T. Kute, P. Heidemann, 1978, Cancer Research.

Specific estrogen-binding capacity of the cytoplasmic receptor in normal and neoplastic breast tissues of humans.

J. Wittliff, R. Orlando, R. Hilf, 1972, Cancer research.

Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.

C. Redmond, D. Wickerham, N. Wolmark, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlation of estrogen, progesterone, and androgen receptors in breast cancer.

L. Ellis, K. Bland, J. Wittliff, 1989, American journal of surgery.

Lability of steroid hormone receptors following devascularization of breast tumors.

L. Ellis, K. Bland, W. Souba, 1989, Archives of surgery.

High-resolution separation of molybdate-stabilized progestin receptors using high-performance liquid chromatography.

J. Wittliff, L. van der Walt, 1988, Journal of chromatography.

Assessment of progestin receptor polymorphism by various synthetic ligands using HPLC.

J. Wittliff, L. van der Walt, 1986, Journal of steroid biochemistry.

Steroid hormone receptors in adrenal cortical carcinoma.

J. Wittliff, J. Sanfilippo, 1984, American journal of obstetrics and gynecology.

Clinical correlations of steroid receptors and male breast cancer.

W. McGuire, M. Lippman, J. Wittliff, 1980, Cancer research.

Concentration of glucocorticoid receptor sites in normal human lymphocytes.

J. Wittliff, A. Steiner, 1986, Clinical chemistry.

A Whole-Cell AssayforGlucocorticoid Binding Sitesin NormalHuman Lymphocytes

J. Wittliff, A. Steiner, 1985 .

Characteristicsof Progesterone-bindingComponentsin Neoplastic MammaryTissues of the Rat1

J. Wittliff, J. Goral, 1976 .

Mechanisms of Action of Estrogens

J. Wittliff, R. Hilf, 1975 .

Influence of Biopsy Size on Sex‐Steroid Receptor Levels Determined by Enzyme Immunoassay

J. Wittliff, Matthew L. Offutt, S. Miseljic, 1995 .

14C-labeled proteins as markers for gradient analysis of steroid-hormone receptors.

J. Wittliff, P. Feldhoff, R. Feldhoff, 1981, Clinical chemistry.

Mechanism of Fusarium mycotoxin action in mammary gland.

J. Wittliff, P. Boyd, 1978, Journal of toxicology and environmental health.

Specific estrogen receptors in the lactating mammary gland of the rat.

D. Gardner, J. Wittliff, 1973, Biochemistry.

Studies on certain cytoplasmic enzymes and specific estrogen receptors in human breast cancer and in nonmalignant diseases of the breast.

J. Wittliff, R. Orlando, R. Hilf, 1973, Cancer research.

Alterations in sex-steroid hormone receptors during mammary gland differentiation in the rat.

J. Wittliff, R. Wiehle, 1983, Comparative biochemistry and physiology. B, Comparative biochemistry.

Molybdate and the molecular properties of the vervet monkey estrogen receptor.

J. Wittliff, H. Potgieter, N. Savage, 1986, Journal of steroid biochemistry.

Expression of urokinase‐type plasminogen activator and plasminogen activator inhibitor in colon disease

J. Wittliff, S. Galandiuk, S. Miseljic, 1995, Journal of clinical laboratory analysis.

Structural and functional analysis of N-terminal point mutants of the human estrogen receptor

T. Butt, J. Wittliff, A. Jungbauer, 1996, The Journal of Steroid Biochemistry and Molecular Biology.

Simultaneous identification of estrogen and progesterone receptors by HPLC using a double isotope assay

J. Wittliff, P. Folk, Jing Dong, 1992, The Journal of Steroid Biochemistry and Molecular Biology.

Steroid hormone-receptor activity in the presence of a mycotoxic phomopsin toxin and the sesquiterpene ivalin toxin.

J. Wittliff, C. V. van Aswegen, C. van Aswegen, 1985, Journal of toxicology and environmental health.

Rapid, high-resolution procedure for assessment of estrogen receptor heterogeneity in clinical samples.

J. Wittliff, N. Shahabi, D. M. Boyle, 1985, Journal of chromatography.

Steroid receptor and growth factor receptor expression in human nonsmall cell lung cancers using cells procured by laser-capture microdissection.

J. Wittliff, J. Eliason, A. Kerr, 2008, Advances in experimental medicine and biology.

Determination of radioactivity in polyacrylamide gel slices mounted on solid supports.

J. Wittliff, J. Leinen, 1978, Analytical biochemistry.

Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.

J. Wittliff, G. Barrows, G. Schultz, 1984, Cancer research.

Characterization of estrogen response element binding proteins as biomarkers of breast cancer behavior.

Timothy D Cummins, J. Wittliff, Traci L. Kruer, 2013, Clinical biochemistry.

Quantitative analyses of epidermal growth factor receptors, HER‐2/neu oncoprotein and cathepsin D in nonmalignant and malignant uteri

D. Doering, J. Wittliff, J. Sanfilippo, 1996, Cancer.

Potent Inhibitors of LXXLL‐Based Protein–Protein Interactions

J. Trent, J. Wittliff, K. Bramlett, 2005, Chembiochem : a European journal of chemical biology.

Thioether side chain cyclization for helical peptide formation: inhibitors of estrogen receptor-coactivator interactions.

J. Wittliff, K. Bramlett, T. Burris, 2004, The journal of peptide research : official journal of the American Peptide Society.

The steroid receptors of experimental mammary tumors and their relationship to those of human breast carcinoma

J. Wittliff, 1979 .

The effect of pregnancy on hormone levels and receptors in malignant melanoma

J. Wittliff, C. Sutherland, W. Mabie, 1983, Journal of surgical oncology.

Further studies of biochemical predictive tests in breast cancer

J. Wittliff, R. Hilf, E. Savlov, 1977, Cancer.

Estrogen specificity of the induction of lipovitellin syntheses and evidence for a specific estrogen-binding component.

J. Wittliff, P. R. Zelson, 1974, Endocrine Research Communications.

Steroid receptor interactions in human breast carcinoma

J. Wittliff, 1980, Cancer.

Nuclear interaction of Fusarium mycotoxins with estradiol binding sites in the mouse uterus.

R. Mehta, J. Wittliff, D. L. Greenman, 1979, Journal of toxicology and environmental health.

Characterization of a distinct glucocorticoid-binding protein in the lactating mammary gland of the rat.

D. Gardner, J. Wittliff, 1973, Biochimica et biophysica acta.

Secretion of lipovitellin into serum following induction of synthesis in the liver by estradiol-17 .

J. Wittliff, P. R. Zelson, 1973, Endocrinology.

Regulation of yolk protein synthesis in amphibian liver. I. Induction of lipovitellin synthesis by estrogen.

F. Kenney, J. Wittliff, 1972, Biochimica et biophysica acta.

Regulation of yolk protein synthesis in amphibian liver. II. Elevation of ribonucleic acid synthesis by estrogen.

F. Kenney, K. L. Lee, J. Wittliff, 1972, Biochimica et biophysica acta.

High-performance hydrophobic interaction chromatography of estrogen receptors and magnesium dependent protein kinase(s): detection of two molecular forms of estrogen receptors in the presence and absence of sodium molybdate.

J. Wittliff, S. Hyder, N. Sato, 1988, Journal of steroid biochemistry.

High-performance size exclusion chromatography as a rapid method for the separation of steroid hormone receptors.

J. Wittliff, R. Wiehle, G. E. Hofmann, 1984, Journal of chromatography.

Characterisation of non-activated and activated estrogen- and antiestrogen-receptor complexes by high performance ion exchange chromatography.

J. Wittliff, L. Myatt, 1986, Journal of steroid biochemistry.

Detection and partial characterization of receptors for [D-Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma.

A. Schally, G. Srkalović, J. Wittliff, 1990, Cancer research.

Estrogen receptor is associated with protein and phospholipid kinase activities.

J. Wittliff, A. Baldi, D. M. Boyle, 1986, Biochemical and biophysical research communications.

Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy

M. Ingelman-Sundberg, E. Baulieu, J. Wittliff, 1989, Progress in Clinical Biochemistry and Medicine.

Epidermal Growth Factor Binding by Breast Tumor Biopsies and Relationship to Estrogen Receptor and Progestin Receptor Levels 1

J. Wittliff, G. Barrows, G. Schultz, 2006 .

Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer.

D. Doering, J. Meyer, J. Wittliff, 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

PAROTOID GLAND SECRETIONS IN TWO SPECIES GROUPS OF TOADS (GENUS BUFO)

J. Wittliff, 1962 .

Protein Tyrosine Phosphatase 4A2 Expression Predicts Overall and Disease-Free Survival of Human Breast Cancer and Is Associated with Estrogen and Progestin Receptor Status

S. A. Andres, J. Wittliff, James L Wittliff, 2013, Hormones and Cancer.

Comparison of sex steroid receptor determinations in human breast cancer by enzyme immunoassay and radioligand binding

B. Djulbegovic, J. Wittliff, R. Pasic, 1990, Journal of clinical laboratory analysis.

Estrogen receptor assay: interlaboratory and intralaboratory variations in the measurement of receptors using dextran-coated charcoal technique: a study sponsored by E.C.O.G.

R. Gelman, J. Wittliff, H. Jacobson, 1981, European journal of cancer.

Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue

S. A. Andres, J. Wittliff, 2011, Endocrine.

Glucocorticoid receptors in normal human lymphocytes and human leukemia and lymphoma cells

J. Wittliff, A. Steiner, 1988 .

Treatment in vivo of R3230AC carcinoma of the rat with estradiol mustard (NSC-112259) of its molecular components.

J. Wittliff, R. Everson, T. Hall, 1973, Cancer chemotherapy reports.

Glucocorticoid-binding components in an irradiation-induced thymoma of the C57BL-6J mouse.

R. Brown, J. Wittliff, J. Leinen, 1974, Cancer research.

Expression of Genes for Methylxanthine Pathway-Associated Enzymes Accompanied by Sex Steroid Receptor Status Impacts Breast Carcinoma Progression

J. Wittliff, M. Daniels, Seth B Sereff, 2017, Hormones and Cancer.

Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.

E. H. Fowler, J. Wittliff, E. Boylan, 1977, British Journal of Cancer.

Specific estrogen binding in vivo in the R3230AC mammary adenocarcinoma of the rat.

J. Wittliff, E. Boylan, E. S. Boylan, 1973, Cancer research.

Steroid-hormone-binding proteins in normal and neoplastic mammary tissues from C3H mice fed diethylstilbestrol.

J. Wittliff, W. Lewko, 1983, Journal of toxicology and environmental health.

Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat.

J. Wittliff, E. Boylan, R. E. Calhoon, 1981, Journal of toxicology and environmental health.

Methods of steroid receptor analyses and their quality control in the clinical laboratory.

J. Wittliff, J. Durant, B. Fisher, 1981, Progress in clinical and biological research.

Progestin binding in mammary tissue of prepartum, nonlactating and postpartum, lactating cows

J. Wittliff, A. Capuco, R. Akers, 1982, Steroids.

Steroid‐hormone receptors in breast cancer

J. Wittliff, 1984, Cancer.

Assessment of "activation" of estrogen receptors in lactating mammary gland using DNA-cellulose binding.

J. Wittliff, D. Park, 1977, Biochemical and biophysical research communications.

Steroid-binding proteins of the mammary gland and their clinical significance in breast cancer.

R. Mehta, J. Wittliff, P. Boyd, 1976, Journal of toxicology and environmental health. Supplement.

Specific estrogen binding in rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene.

J. Wittliff, E. Boylan, E. S. Boylan, 1975, Cancer research.

Specific estrogen-receptors in the neoplastic and lactating mammary gland of the rat.

D. Gardner, J. Wittliff, P. Gilbert, 1972, Biochemical and biophysical research communications.

Characteristics of [3H]progesterone-bmnding components were studied in cell-free preparations of two hormonally responsive tumors: the R3230AG mammary adenocarci noma and 9,10-dimethyl-1 ,2-benzanthracene-induced mam

J. Wittliff, J. Goral, 2006 .

Identification and partial characterization of specific estrogen receptors in the vole (Microtus montanus).

J. Wittliff, P. C. Beers, 1973, Comparative biochemistry and physiology. B, Comparative biochemistry.

Quantitation of radio-ligand binding data using a desk-top calculator in the program mode.

J. Wittliff, W. Brooks, 1973, Analytical biochemistry.

Characteristics of progesterone-binding components in neoplastic mammary tissues of the rat.

J. Wittliff, J. Goral, 1976, Cancer research.

Demonstration of a Glucocorticoid Hormone-receptor Complex in the Cytoplasm of a Hormone-Responsive Tumour

D. Gardner, J. Wittliff, 1973, British Journal of Cancer.

High-Performance Liquid Chromatography as a Means of Characterizing Isoforms of Steroid Hormone Receptor Proteins

J. Wittliff, L. Myatt, S. Hyder, 1987 .

PROPERTIES OF SPECIFIC ESTROGEN-BINDING COMPONENTS IN HUMAN KIDNEY AND RENAL CARCINOMA

H. Bojar, J. Wittliff, K. Balzer, 1975 .

Comparison of glucocorticoid-binding proteins in normal and neoplastic mammary tissues of the rat.

J. Wittliff, J. Goral, 1975, Biochemistry.

Biochemical basis for the selection of hormonal manipulation in the patient with breast carcinoma.

J. Wittliff, E. Savlov, 1978, International journal of radiation oncology, biology, physics.

Oestrogen-Binding Components in Human Renal Cell Carcinoma

H. Bojar, J. Wittliff, K. Balzer, 1976, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Identification and Partial Characterization of Specific Oestrogen-Binding Components in Human Kidney

H. Bojar, J. Wittliff, K. Balzer, 1976, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Glucocorticoid-binding macromolecules in the lactating mammary gland of the vole.

J. Wittliff, R. Turnell, P. C. Beers, 1974, Endocrinology.

Rapid analysis of estrogen receptor heterogeneity by chromatofocusing with high-performance liquid chromatography.

T. Hutchens, J. Wittliff, N. Shahabi, 1983, Journal of chromatography.

â€œestrogen-bindingproteinsâ€•or â€œestrogenreceptors ,â€œprecedes alterations in the rates of synthesis of nucleic acids and proteins. Administration in vivo of certain antiuterotropic

J. Wittliff, R. Orlando, R. Hilf, 2006 .

Epigenetic analysis of laser capture microdissected fetal epithelia.

S. A. Andres, J. Wittliff, R. Greene, 2013, Analytical biochemistry.

Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial.

C. Redmond, D. Wickerham, N. Wolmark, 1987, Annals of internal medicine.

Co-expression of genes with estrogen receptor-α and progesterone receptor in human breast carcinoma tissue

S. A. Andres, J. Wittliff, 2012, Hormone molecular biology and clinical investigation.

Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer.

D. Doering, J. Meyer, J. Wittliff, 2001, Gynecologic oncology.

Relationships of protein biomarkers of the urokinase plasminogen activator system with expression of their cognate genes in primary breast carcinomas

J. Wittliff, M. Daniels, Seth B Sereff, 2019, Journal of clinical laboratory analysis.

Characteristics and distribution of receptors for [d‐trp6]‐ luteinizing hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer

A. Schally, J. Wittliff, M. Fekete, 1989, Journal of clinical laboratory analysis.

ADVERSE EFFECT OF TAMOXIFEN WITH LHRH AGONIST ON OESTROGEN-RECEPTOR-NEGATIVE MAMMARY CARCINOMA

B. Szende, A. Schally, G. Srkalović, 1989, The Lancet.

Treatment of primary breast cancer with chemotherapy and tamoxifen.

C. Redmond, N. Wolmark, B. Fisher, 1981, The New England journal of medicine.

Precision in estrogen and progesterone receptor assays. Results of the first CAP pilot survey.

D. Oxley, J. Wittliff, G. Haven, 1982, American journal of clinical pathology.

Clinical outcomes linked to expression of gene subsets for protein hormones and their cognate receptors from LCM-procured breast carcinoma cells

Guy N. Brock, James L. Wittliff, J. Wittliff, 2016, Breast Cancer Research and Treatment.

A Five-Gene Model Predicts Clinical Outcome in ER+/PR+, Early-Stage Breast Cancers Treated with Adjuvant Tamoxifen

J. Wittliff, D. Kerr, 2011, Hormones & cancer.

Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer.

A. Schally, J. Wittliff, M. Ben-david, 1988, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Laser capture microdissection and its applications in genomics and proteomics.

M. Erlander, J. Wittliff, 2002, Methods in enzymology.

ClinicalCorrelationsof Steroid Receptorsand Male BreastCancer

W. McGuire, M. Lippman, J. Wittliff, 2006 .

A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer

K. Bland, J. Wittliff, T. Woodcock, 1982, Breast Cancer Research and Treatment.

Influence of danazol on cytoplasmic and nuclear estrogen binding capacity in the uterus.

J. Wittliff, J. R. Melvin, J. Sanfilippo, 1983, American journal of obstetrics and gynecology.

Interrogating differences in expression of targeted gene sets to predict breast cancer outcome

Guy N Brock, S. A. Andres, J. Wittliff, 2013, BMC Cancer.

Preparation of cytosol for steroid receptor determinations with the Beckman "Airfuge".

J. Wittliff, P. Heidemann, 1979, Clinical chemistry.

Rapid purification of topoisomerase I from human breast cancer cells by high-performance liquid chromatography.

M. Crespi, J. Wittliff, S. Hyder, 1986, Journal of chromatography.

Expression of hormone receptors, cathepsin D, and HER-2/neu oncoprotein in normal colon and colonic disease.

J. Wittliff, S. Galandiuk, M. Early, 1993, Archives of surgery.

Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer-Clinical Notice

Anthony Rhodes, Paul Valenstein, Daniel F. Hayes, 2010 .

Use of high-performance liquid chromatography in the evaluation of the synthesis and binding of fluorescein linked steroids to estrogen receptors.

J. Wittliff, N. C. Clements, M. Lonsdorfer, 1983, Journal of chromatography.

Demonstration of specific glucocorticoid binding sites in bovine cornea.

J. Wittliff, R. Eiferman, M. Lin, 1984, Experimental eye research.

Comparison of steroid receptor levels in renal‐cell carcinoma and autologous normal kidney

J. Wittliff, J. Durant, George P. Hemstreet, 1980, International journal of cancer.

Interaction between smoking history and gene expression levels impacts survival of breast cancer patients

Katie E. Bickett, T. Kalbfleisch, S. A. Andres, 2015, Breast Cancer Research and Treatment.

Estrogens III: Phytoestrogens and Mycoestrogens

J. Wittliff, 2005 .

Biosensor, ELISA, and frog embryo teratogenesis assay: Xenopus (FETAX) analysis of water associated with frog malformations in Minnesota

Joseph A. Magner, James G. Downward, Eric A. E. Garber, 2001, SPIE Optics East.

Relationship of glycolytic enzyme activities and response of breast cancer patients to chemotherapy. A preliminary report

J. Wittliff, Russell Hilf, Edwin D. Savlov, 1976, Cancer.

Expression of Epidermal Growth Factor Receptors in Human Breast Cancer: Mass Versus Ligand Binding Capacity

J. Wittliff, V. J. Cline, S. Miseljic, 1995 .

Characteristics of the Human Estrogen Receptor Protein Produced in Microbial Expression Systems

T. Butt, J. Wittliff, P. Folk, 1994 .

The effects of ischemia on estrogen and progesterone receptor profiles in the rodent uterus.

K. Bland, J. Wittliff, Y. J. He, 1987, The Journal of surgical research.

Assessment of estrogen receptor-monoclonal antibody interaction by high-performance liquid chromatography.

J. Wittliff, D. W. Brandt, 1986, Journal of chromatography.

Interaction of estrogen receptor isoforms with immobilized monoclonal antibodies.

J. Wittliff, S. Hyder, L. Chang, 1986, Journal of chromatography.

Cytochrome P-450 activity in human leiomyoma and normal myometrium.

W. Dean, J. Wittliff, G. Barrows, 1985, American journal of obstetrics and gynecology.

Procedures for measuring cytochrome P-450-dependent hydroxylation activity in reproductive tissues.

W. Pierce, W. Dean, J. Wittliff, 1985, Analytical biochemistry.

Polymorphism of estrogen receptors in human breast cancer.

J. Wittliff, P. Feldhoff, R. Wiehle, 1981, Progress in clinical and biological research.

Separation of two molecular forms of human estrogen receptor by hydrophobic interaction chromatography. Gradient optimization and tissue comparison.

J. Wittliff, S. Hyder, 1989, Journal of chromatography.

High-performance hydrophobic interaction chromatography as a means of identifying estrogen receptors expressing different binding domains.

J. Wittliff, S. Hyder, 1988, Journal of chromatography.

Characterization of estrogen receptors and associated protein kinase activity by high-performance hydrophobic-interaction chromatography.

J. Wittliff, S. Hyder, N. Sato, 1987, Journal of chromatography.

Isoforms of estrogen receptors by high-performance ion-exchange chromatography.

J. Wittliff, R. Wiehle, 1984, Journal of chromatography.

Monoclonal antibody recognition of estrogen receptor isoforms

J. Wittliff, S. Hyder, A. Baldi, 1986 .

HPLC analysis of estrogen receptor by a multidimensional approach.

J. Wittliff, S. Hyder, N. Shahabi, 1986, Journal of steroid biochemistry.

Relation between cathepsin D expression and other prognostic factors in breast carcinomas.

J. Wittliff, R. Wiehle, R. Shaheen, 1995, Clinical chemistry.

Influence of O.C.T. embedding compound on determinations of estrogen and progestin receptors in breast cancer.

B. Djulbegovic, J. Wittliff, R. Pasic, 1989, Clinical chemistry.

Influence of certain prostaglandin synthetase inhibitors on cytoplasmic estrogen receptors in the uterus.

J. Wittliff, J. R. Melvin, J. Sanfilippo, 1983, American journal of obstetrics and gynecology.

Detection of two high molecular weight hydrophobic forms of the human estrogen receptor.

J. Wittliff, S. Hyder, 1989, Journal of steroid biochemistry.

High-performance hydrophobic-interaction chromatography of steroid hormone receptors.

J. Wittliff, S. Hyder, R. Wiehle, 1985, Journal of chromatography.

Dephosphorylation in Vitro Inhibits Ligand and DNA Binding Activities of Human Estrogen Receptor

J. Wittliff, P. Folk, 1993 .

Alterations in estrogen receptor isoforms in the mammary gland and uterus of the rat during differentiation.

J. Wittliff, S. Hyder, R. Wiehle, 1988, Comparative biochemistry and physiology. B, Comparative biochemistry.

Expression and characterization of an active human estrogen receptor as a ubiquitin fusion protein from Escherichia coli.

Z. Nawaz, J. Dong, T. Butt, 1990, Journal of Biological Chemistry.

Assessment of phytoestrogen and mycoestrogen recognition by recombinant human estrogen receptor-α using ligand titration arrays.

S. A. Andres, J. Wittliff, Stefanie B. Bumpus, 2013, Phytochemical analysis : PCA.

Molecular signatures of estrogen receptor-associated genes in breast cancer predict clinical outcome.

S. A. Andres, J. Wittliff, Irina A. Smolenkova, 2008, Advances in experimental medicine and biology.

A three-tiered approach for calibration of a biosensor to detect estrogen mimics.

S. A. Andres, J. Wittliff, Stefanie B. Bumpus, 2008, Advances in experimental medicine and biology.

Influence of phomopsin and ivalin on steroid-hormone binding and growth of MCF-7 human breast cancer cells.

J. Wittliff, W. Lewko, C. V. van Aswegen, 1985, Journal of toxicology and environmental health.

Special report. Steriod receptors in breast cancer.

W. McGuire, P. Carbone, J. Wittliff, 1979, The New England journal of medicine.

Comparison of cathepsin d determinations in human carcinomas by enzyme immunoassay and immunoradiometric assay

D. Doering, J. Wittliff, R. M. Shaheen, 1995, Journal of clinical laboratory analysis.

ClinicalCorrelationsof SteroidReceptorsand MaleBreastCancer1

W. McGuire, M. Lippman, J. Wittliff, 1980 .

Venom constituents of Bufo fowlerl, Bufo valliceps, and their natural hybrids analyzed by electrophoresis and chromatography

J. Wittliff, 1964 .

Interaction of angiogenesis inhibitor TNP-470 with basic fibroblast growth factor receptors.

J. Wittliff, G. Anderson, S. Klein, 2000, The Journal of surgical research.

Estrogen and progestin receptors in human uterus: reference ranges of clinical conditions.

J. Wittliff, J. Sanfilippo, J. Siegel, 1986, Clinical physiology and biochemistry.

Southeastern Cancer Study Group: breast cancer studies 1972-1982.

J. Lefante, C. Perez, C. Vogel, 1983, International journal of radiation oncology, biology, physics.

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

M. Dowsett, D. Visscher, M. Hammond, 2010, Journal of oncology practice.

Immunohistochimie quantitative (qihc)

R. Salunga, M. Erlander, J. Wittliff, 2002 .

A Novel Protein Kinase Activity Identified from Human Breast Cancer Cell Lines

J. Wittliff, A. Baldi, D. M. Boyle, 1992 .

Temporal Expression of miRNAs in Laser Capture Microdissected Palate Medial Edge Epithelium from Tgfβ3(-/-) Mouse Fetuses.

M. Pisano, J. Wittliff, R. Greene, 2015, MicroRNA.

Evaluation of danazol influence upon the uterus using scanning electron microscopic morphometric and biochemical analyses.

J. Wittliff, R. Apkarian, G. Barrows, 1985, Surgery, gynecology & obstetrics.

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

M. Dowsett, L. McShane, D. Allred, 2010, Journal of oncology practice.

The extracellular thiaminase I of Bacillus thiaminolyticus. II. Preparation of the antisera and serological properties.

J. Wittliff, R. Airth, W. Mandy, 1968, Biochemistry.

A whole-cell assay for glucocorticoid binding sites in normal human lymphocytes.

J. Wittliff, A. Steiner, 1985, Clinical chemistry.

Influence of sialic acid on the binding activity of estrogen receptors.

J. Wittliff, P. Becker, H. van Rensburg, 1990, Clinical physiology and biochemistry.